Dihydroartemisinin is potential therapeutics for treating late-stage CRC by targeting the elevated c-Myc level

Xianjing Hu, Sarwat Fatima, Minting Chen, Tao Huang, Yuen Wa Chen, Ruihong Gong, Hoi Leong Xavier Wong, Rongmin Yu, Liyan Song, Hiu Yee Kwan*, Zhaoxiang Bian*

*Corresponding author for this work

Research output: Contribution to journalJournal articlepeer-review

5 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Dihydroartemisinin is potential therapeutics for treating late-stage CRC by targeting the elevated c-Myc level'. Together they form a unique fingerprint.

Keyphrases

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science